Stefano Pepe
Via Salvador Allende 43
Baronissi, 84031, Italy
Baronissi, 84031, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy.
Journal: Journal of medicinal chemistry
Published: February 23, 2026
Cancer in migrant populations: evidence from a regional oncology network.
Journal: BMC public health
Published: January 23, 2026
Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand-Ir(III) Complex Conjugates.
Journal: Cancer communications (London, England)
Published: December 16, 2025
rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in patients with advanced cancer treated with anti-PD-1/PD-L1 therapy.
Journal: Journal for immunotherapy of cancer
Published: November 05, 2025
BRCA1-Associated Protein 1 (BAP1) in Human Cancer and its Emerging Role as a Novel Potential Therapeutic Target.
Journal: Current oncology reports
Published: October 19, 2025
Pathological complete response in a POLE-mutated non-small cell lung cancer patient treated with perioperative chemoimmunotherapy: a case report and review of the literature.
Journal: MedScience
Published: September 27, 2025
Refining multiple artificial intelligence strategies for automatic pain assessment investigations (RUGGI Study): A study protocol.
Journal: European journal of anaesthesiology and intensive care
Published: July 31, 2025
Gastric cancer, what's new from International Gastric Cancer Congress (IGCC) in Amsterdam: a scientific report from Salerno 2025 conference.
Journal: Ecancermedicalscience
Published: July 21, 2025
Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanoma.
Journal: Translational oncology
Published: February 14, 2025
Association between opioid use and survival in advanced non small cell lung cancer patients treated with immune checkpoint inhibitors.
Journal: Scientific reports
Published: January 25, 2025
KRAS mutations in advanced non-small cell lung cancer: From biology to novel therapeutic strategies.
KRAS mutations in advanced non-small cell lung cancer: From biology to novel therapeutic strategies.
Journal: Critical reviews in oncology/hematology
Published: May 16, 2024
Last Updated: 09/26/2026